查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1701683

哺乳动物细胞库市场：全球产业分析、规模、份额、成长、趋势与预测（2025-2032）

Mammalian Cell Banking Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 251 Pages | 商品交期: 2-5个工作天内

价格
简介目录

预计 2025 年全球哺乳动物细胞库市场规模将达到 5.67 亿美元，到 2032 年将达到 14.188 亿美元，预测期内（2025-2032 年）的复合年增长率为 14.0%。

哺乳动物细胞库市场涉及对生技药品製造、基因治疗和疫苗生产至关重要的哺乳动物衍生细胞株的开发、储存和维护。细胞库确保生物製药生产的一致性、品质和安全性。随着全球对单株抗体、细胞和基因疗法以及个人化医疗的需求不断增加，哺乳动物细胞库已成为确保可靠和扩充性生产过程的关键要素。

由于多种驱动因素​​，哺乳动物细胞库市场正在经历强劲成长。一个主要驱动因素是对生技药品和生物相似药日益增长的需求，这需要稳定且特征明确的哺乳动物细胞株来进行生产。人们对个人化医疗和细胞/基因治疗的兴趣日益浓厚，进一步加速了对安全、高品质细胞库系统的需求。基于 CRISPR 的工程和高通量筛检等细胞株开发技术的进步也促进了市场扩张。此外，对细胞库使用良好生产规范 (GMP) 的监管支援正在提高产品品质和合规性，推动市场向前发展。

儘管哺乳动物细胞库市场具有成长潜力，但也面临一些挑战。建立符合 GMP 标准的设施所需的高额初始投资和营运成本可能是一个重大障碍，尤其是对于中小型企业而言。此外，新细胞株的复杂而漫长的监管核准流程可能会减缓产品开发。长期储存还存在与污染、基因漂变和变异相关的风险，这需要严格的品管和监控系统，从而增加了成本和复杂性。

哺乳动物细胞库市场提供了大量的扩张和创新机会。涉及生技药品和先进疗法的临床试验的增加，特别是在肿瘤学和罕见疾病领域，正在推动多样化和可靠细胞库的需求。亚太和拉丁美洲的新兴市场正在迅速扩大其生物製药生产能力，提供了新的商业前景。此外，生物製药公司和 CRO 越来越多地合作外包细胞库服务，以提供扩充性和效率。对自动化和数位技术的投资，例如人工智慧驱动的品管和数位生物银行平台，也为更高的标准化和卓越营运打开了大门。

本报告研究了全球哺乳动物细胞库市场，并深入了解了各地区的趋势、应用和最终用户，以及参与市场的公司的概况。

目录

第一章执行摘要

第二章 市场概述

第三章 主要市场趋势

第四章 关键成功因素

  • 管道评估
  • 价值链分析
  • 各大厂商主要促销策略
  • 监管状况
  • PESTLE分析
  • 波特分析

第五章 市场背景

第六章 COVID-19 危机—影响评估

  • COVID-19 及其影响分析
  • 2022 年市场前景

7. 2019-2032年全球哺乳动物细胞库市场展望

  • 2019-2024年历史市场价值分析
  • 2025 年至 2032 年当前和未来市场价值预测

8. 2019-2032 年全球哺乳动物细胞库市场展望（依细胞类型）

  • 简介/主要发现
  • 2019 年至 2024 年按电池类型分類的历史市场规模分析
  • 2025 年至 2032 年按电池类型分類的当前和未来市场规模分析与预测
  • 按细胞类型分析市场吸引力

9. 2019-2032 年全球哺乳动物细胞库市场展望（依技术）

  • 简介/主要发现
  • 2019 年至 2024 年按技术分類的历史市场规模分析
  • 2025 年至 2032 年按技术分類的当前与未来市场规模分析与预测
  • 依技术进行市场吸引力分析

第 10 章 2019-2023 年全球哺乳动物细胞库市场展望（按应用）

  • 简介/主要发现
  • 2019 年至 2024 年按应用分類的历史市场规模分析
  • 当前和未来市场规模分析与预测（按应用），2025 年至 2032 年
  • 按应用进行市场吸引力分析

第 11 章。 2019-2032 年全球哺乳动物细胞库市场展望（按最终用户划分）

  • 简介/主要发现
  • 2019 年至 2024 年最终用户市场规模历史分析
  • 2025 年至 2032 年按最终用户分類的当前和未来市场规模分析和预测
    • 学术研究所
    • 生物製药公司
    • CRO
  • 最终用户的市场吸引力分析

第 12 章。 2019-2032 年全球哺乳动物细胞库市场展望（按地区）

  • 介绍
  • 2019 年至 2024 年各地区历史市场规模分析
  • 2025 年至 2032 年各地区现今及未来市场规模分析与预测
    • 北美洲
    • 拉丁美洲
    • 欧洲
    • 东亚
    • 南亚
    • 大洋洲
    • 中东和非洲
  • 区域市场吸引力分析

13. 北美哺乳动物细胞库市场展望，2019 - 2032

14. 2019 - 2032 年拉丁美洲哺乳动物细胞库市场展望

15. 2019-2032年欧洲哺乳动物细胞库市场展望

16. 南亚哺乳动物细胞库市场展望，2019-2032

17. 东亚哺乳动物细胞库市场展望，2019-2032

18.大洋洲哺乳动物细胞库市场

19. 中东和非洲哺乳动物细胞库市场展望，2019 - 2032

第二十章市场结构分析

第21章 竞争分析

  • 竞争仪錶板
  • 竞争基准
  • 衝突详情
    • Eurofins DiscoverX Corporation
    • Merck KGaA
    • Sartorius Stedim BioOutsource Limited.
    • Charles River Laboratories
    • Altogen Labs
    • Abzena Ltd
    • Northway Biotechpharma
    • Lonza Group Ltd
    • VIRUSURE
    • Selexis SA
    • Sigma-Aldrich
    • Takara Bio Inc

第 22 章使用的假设和缩写词

第23章调查方法

简介目录
Product Code: PMRREP31663

Persistence Market Research has recently released a comprehensive report on the global Mammalian Cell Banking Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Mammalian Cell Banking Market Size (2025E): USD 567.0 Mn
  • Projected Market Value (2032F): USD 1,418.8 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 14.0%

Mammalian Cell Banking Market - Report Scope:

The mammalian cell banking market includes the development, storage, and maintenance of cell lines derived from mammalian cells, which are essential for biologics manufacturing, gene therapy, and vaccine production. Cell banks ensure consistency, quality, and safety in the production of biopharmaceuticals. As demand for monoclonal antibodies, cell and gene therapies, and personalized medicine increases globally, mammalian cell banking has become a critical component in ensuring reliable and scalable production processes.

Market Growth Drivers:

The mammalian cell banking market is experiencing strong growth driven by several influential factors. A major driver is the rising demand for biologics and biosimilars, which require stable and well-characterized mammalian cell lines for production. The increasing focus on personalized medicine and cell & gene therapies has further accelerated the need for secure and high-quality cell banking systems. Technological advancements in cell line development, such as CRISPR-based engineering and high-throughput screening, are also contributing to market expansion. In addition, regulatory support for the use of Good Manufacturing Practices (GMP) in cell banking enhances product quality and compliance, propelling the market forward.

Market Restraints:

Despite its growth potential, the mammalian cell banking market faces some challenges. High initial investment and operational costs associated with establishing GMP-compliant facilities can be a significant barrier, especially for small and mid-sized enterprises. Moreover, the complex and time-consuming regulatory approval processes for new cell lines can delay product development. There are also risks associated with contamination, genetic drift, or variability in long-term storage, which necessitate stringent quality control and monitoring systems, adding to the cost and complexity.

Market Opportunities:

The mammalian cell banking market presents numerous opportunities for expansion and innovation. The increasing number of clinical trials involving biologics and advanced therapies, particularly in oncology and rare diseases, is creating demand for diverse and reliable cell banks. Emerging markets in Asia-Pacific and Latin America are rapidly expanding their biopharmaceutical manufacturing capabilities, offering new business prospects. In addition, collaborations between biopharma companies and CROs to outsource cell banking services are on the rise, enabling scalability and efficiency. Investment in automation and digital technologies, such as AI-driven quality control and digital biobanking platforms, also opens doors for greater standardization and operational excellence.

Key Questions Answered in the Report:

  • What are the primary factors driving the global mammalian cell banking market's growth?
  • Which cell types and applications are dominating the mammalian cell banking landscape?
  • How are biopharmaceutical trends shaping future cell banking strategies?
  • Who are the key players in the mammalian cell banking market, and what strategies are they adopting?
  • What are the growth opportunities in emerging regions?

Competitive Intelligence and Business Strategy:

Leading companies in the mammalian cell banking market, such as Eurofins DiscoverX Corporation, Merck KGaA, Sartorius Stedim BioOutsource Limited, Charles River Laboratories, and Lonza Group Ltd, are focusing on expanding their GMP-compliant manufacturing facilities and enhancing service portfolios to meet global biopharma demand. Strategic partnerships with biotech firms and academic institutes, along with R&D investments in innovative cell line technologies, are key to maintaining a competitive edge. Companies are also emphasizing quality assurance, contamination prevention, and regulatory alignment to boost client confidence and streamline product development pipelines.

Companies Covered in This Report:

  • Eurofins DiscoverX Corporation
  • Merck KGaA
  • Sartorius Stedim BioOutsource Limited
  • Charles River Laboratories
  • Altogen Labs
  • Abzena Ltd
  • Northway Biotechpharma
  • Lonza Group Ltd
  • VIRUSURE
  • Selexis SA
  • Takara Bio Inc

Key Segments Covered in Manufacturing of Industry Research:

Cell Type:

  • CHO
  • BHK
  • NS0
  • YB2/0 & P2/0
  • HEK293 & Derivatives
  • HELA

Technology:

  • TEP
  • IEP
  • SEP

Application:

  • MCB (Master Cell Bank)
  • WCB (Working Cell Bank)
  • EoP (End of Production)
  • R&D CB (Research & Development Cell Bank)

End User:

  • Academic & Research Institutes
  • Biopharmaceutical Companies
  • CROs (Contract Research Organizations)

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply-Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Development/Innovation Trends

4. Key Success Factors

  • 4.1. Pipeline Assessment
  • 4.2. Value chain Analysis
  • 4.3. Key Promotional Strategies, By Key Manufacturers
  • 4.4. Regulatory Landscape
  • 4.5. PESTLE Analysis
  • 4.6. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure
    • 5.1.3. Global Cell Banking Outsourcing Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Key Player's Historic Growth
    • 5.2.2. Market Consolidation Activities
    • 5.2.3. Increasing Geriatric Population
    • 5.2.4. Rising Cases of Cancer
    • 5.2.5. Growing Preference of Mammalian Cell Banking
    • 5.2.6. Increased R&D investments by Government
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Cell
    • 6.1.2. By Technology
    • 6.1.3. By Application
    • 6.1.4. By End User
    • 6.1.5. By Region
  • 6.2. 2022 Market Scenario

7. Global Mammalian Cell Banking Market Outlook, 2019-2032

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2024
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2025-2032
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Mammalian Cell Banking Market Outlook, 2019-2032 , By Cell

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Cell, 2019-2024
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Cell, 2025-2032
  • 8.4. Market Attractiveness Analysis By Cell

9. Global Mammalian Cell Banking Market Outlook, 2019-2032 , By Technology

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) By Technology, 2019-2024
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2025-2032
  • 9.4. Market Attractiveness Analysis By Technology

10. Global Mammalian Cell Banking Market Outlook, 2019-2032 , By Application

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By Application, 2019-2024
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2025-2032
  • 10.4. Market Attractiveness Analysis By Application

11. Global Mammalian Cell Banking Market Outlook, 2019-2032 , By End User

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) By End User, 2019-2024
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2025-2032
    • 11.3.1. Academic & Research Institute
    • 11.3.2. Biopharmaceutical Companies
    • 11.3.3. CROs
  • 11.4. Market Attractiveness Analysis By End User

12. Global Mammalian Cell Banking Market Outlook, 2019-2032 , By Region

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2024
  • 12.3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2025-2032
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. East Asia
    • 12.3.5. South Asia
    • 12.3.6. Oceania
    • 12.3.7. Middle East and Africa (MEA)
  • 12.4. Market Attractiveness Analysis By Region

13. North America Mammalian Cell Banking Market Outlook, 2019-2032

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
    • 13.3.1. By Country
      • 13.3.1.1. U.S.
      • 13.3.1.2. Canada
  • 13.4. Market Attractiveness Analysis
  • 13.5. Market Trends
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. U.S. Mammalian Cell Banking Market Analysis
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
    • 13.8.2. Canada Mammalian Cell Banking Market Analysis
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy

14. Latin America Mammalian Cell Banking Market Outlook, 2019-2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
    • 14.3.1. By Country
      • 14.3.1.1. Mexico
      • 14.3.1.2. Brazil
      • 14.3.1.3. Argentina
      • 14.3.1.4. Rest of Latin America
  • 14.4. Market Attractiveness Analysis
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Mexico Mammalian Cell Banking Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
    • 14.8.2. Brazil Mammalian Cell Banking Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
    • 14.8.3. Argentina Mammalian Cell Banking Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy

15. Europe Mammalian Cell Banking Market Outlook, 2019-2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
    • 15.3.1. By Country
      • 15.3.1.1. Italy
      • 15.3.1.2. Germany
      • 15.3.1.3. U.K
      • 15.3.1.4. France
      • 15.3.1.5. Spain
      • 15.3.1.6. BENELUX
      • 15.3.1.7. Nordic Countries
      • 15.3.1.8. Russia
      • 15.3.1.9. Rest of Europe
  • 15.4. Market Attractiveness Analysis
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. Italy Mammalian Cell Banking Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
    • 15.8.2. Germany Mammalian Cell Banking Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
    • 15.8.3. U.K. Mammalian Cell Banking Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
    • 15.8.4. France Mammalian Cell Banking Market Analysis
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
    • 15.8.5. Spain Mammalian Cell Banking Market Analysis
      • 15.8.5.1. Introduction
      • 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
    • 15.8.6. BENELUX Mammalian Cell Banking Market Analysis
      • 15.8.6.1. Introduction
      • 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
    • 15.8.7. Nordic Countries Mammalian Cell Banking Market Analysis
      • 15.8.7.1. Introduction
      • 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
    • 15.8.8. Russia Mammalian Cell Banking Market Analysis
      • 15.8.8.1. Introduction
      • 15.8.8.2. Market Analysis and Forecast by Market Taxonomy

16. South Asia Mammalian Cell Banking Market Outlook, 2019-2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Indonesia
      • 16.3.1.3. Malaysia
      • 16.3.1.4. Thailand
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Cell
  • 16.4. Market Attractiveness Analysis
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. India Mammalian Cell Banking Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
    • 16.8.2. Indonesia Mammalian Cell Banking Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
    • 16.8.3. Malaysia Mammalian Cell Banking Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
    • 16.8.4. Thailand Mammalian Cell Banking Market Analysis
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy

17. East Asia Mammalian Cell Banking Market Outlook, 2019-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
  • 17.4. Market Attractiveness Analysis
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. China Mammalian Cell Banking Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
    • 17.8.2. Japan Mammalian Cell Banking Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
    • 17.8.3. South Korea Mammalian Cell Banking Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy

18. Oceania Mammalian Cell Banking Market 2019-2024 and Forecast 2025-2032

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
  • 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
    • 18.3.1. By Country
      • 18.3.1.1. Australia
      • 18.3.1.2. New Zealand
  • 18.4. Market Attractiveness Analysis
  • 18.5. Market Trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. Australia Mammalian Cell Banking Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
    • 18.8.2. New Zealand Mammalian Cell Banking Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy

19. Middle East and Africa (MEA) Mammalian Cell Banking Market Outlook, 2019-2032

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
  • 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
    • 19.3.1. By Country
      • 19.3.1.1. GCC Countries
      • 19.3.1.2. Turkey
      • 19.3.1.3. South Africa
      • 19.3.1.4. North Africa
      • 19.3.1.5. Rest of Middle East and Africa
  • 19.4. Market Attractiveness Analysis
  • 19.5. Market Trends
  • 19.6. Key Market Participants - Intensity Mapping
  • 19.7. Drivers and Restraints - Impact Analysis
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. GCC Countries Mammalian Cell Banking Market Analysis
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
    • 19.8.2. Turkey Mammalian Cell Banking Market Analysis
    • 19.8.3. South Africa Mammalian Cell Banking Market Analysis
    • 19.8.4. North Africa Mammalian Cell Banking Market Analysis

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies
  • 20.2. Market Share Analysis of Top Players (%)
  • 20.3. Market Presence Analysis
    • 20.3.1. By Regional Footprint of Players
    • 20.3.2. Cell Footprint of Players
    • 20.3.3. Channel Footprint of Players

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Competition Benchmarking
  • 21.3. Competition Deep Dive
    • 21.3.1. Eurofins DiscoverX Corporation
      • 21.3.1.1. Overview
      • 21.3.1.2. Product & Services Portfolio
      • 21.3.1.3. Key Financials
      • 21.3.1.4. SWOT Analysis
      • 21.3.1.5. Key Developments
      • 21.3.1.6. Sales Footprint
      • 21.3.1.7. Strategy Overview
        • 21.3.1.7.1. Marketing Strategy
        • 21.3.1.7.2. Product Strategy
        • 21.3.1.7.3. Channel Strategy
    • 21.3.2. Merck KGaA
    • 21.3.3. Sartorius Stedim BioOutsource Limited.
    • 21.3.4. Charles River Laboratories
    • 21.3.5. Altogen Labs
    • 21.3.6. Abzena Ltd
    • 21.3.7. Northway Biotechpharma
    • 21.3.8. Lonza Group Ltd
    • 21.3.9. VIRUSURE
    • 21.3.10. Selexis SA
    • 21.3.11. Sigma-Aldrich
    • 21.3.12. Takara Bio Inc

22. Assumptions and Acronyms Used

23. Research Methodology